Your browser doesn't support javascript.
loading
Deep molecular response in patients with chronic phase chronic myeloid leukemia treated with the plasminogen activator inhibitor-1 inhibitor TM5614 combined with a tyrosine kinase inhibitor.
Takahashi, Naoto; Kameoka, Yoshihiro; Onizuka, Makoto; Onishi, Yasushi; Takahashi, Fumiaki; Dan, Takashi; Miyata, Toshio; Ando, Kiyoshi; Harigae, Hideo.
Affiliation
  • Takahashi N; Akita University School of Medicine, Akita, Japan.
  • Kameoka Y; Akita University School of Medicine, Akita, Japan.
  • Onizuka M; Tokai University School of Medicine, Isehara, Japan.
  • Onishi Y; Tohoku University, Sendai, Japan.
  • Takahashi F; Iwate Medical University, Morioka, Japan.
  • Dan T; Renascience Inc., Tokyo, Japan.
  • Miyata T; Tohoku University, Sendai, Japan.
  • Ando K; Tokai University School of Medicine, Isehara, Japan.
  • Harigae H; Tohoku University, Sendai, Japan.
Cancer Med ; 12(4): 4250-4258, 2023 02.
Article in En | MEDLINE | ID: mdl-36151699
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Leukemia, Myeloid, Chronic-Phase Type of study: Clinical_trials Limits: Female / Humans / Male / Middle aged Language: En Journal: Cancer Med Year: 2023 Document type: Article Affiliation country: Japan Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Leukemia, Myeloid, Chronic-Phase Type of study: Clinical_trials Limits: Female / Humans / Male / Middle aged Language: En Journal: Cancer Med Year: 2023 Document type: Article Affiliation country: Japan Country of publication: United States